Director at Quest Diagnostics (NYSE: DGX) gets 215 RSUs

Rhea-AI Filing Summary

WENTWORTH TIMOTHY C reported acquisition or exercise transactions in this Form 4 filing.

Quest Diagnostics director Timothy C. Wentworth received an equity award of 215 shares of Common Stock in the form of restricted stock units. The grant was reported at a price of $0.00 per share as compensation, not a market purchase. Following this award, his directly owned position reported in this filing is 215 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider WENTWORTH TIMOTHY C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	215	$0.00	--

Holdings After Transaction: Common Stock — 215 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WENTWORTH TIMOTHY C

(Last) (First) (Middle)

500 PLAZA DRIVE

C/O QUEST DIAGNOSTICS INC

(Street)

SECAUCUS NJ 07094

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QUEST DIAGNOSTICS INC [ DGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/09/2026		A		215	A	$0	215	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units.

Remarks:

	Sean D. Mersten, Attorney in Fact for Timothy C. Wentworth	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Quest Diagnostics (DGX) insider Timothy C. Wentworth report on this Form 4?

Timothy C. Wentworth reported receiving an equity award of 215 shares of Quest Diagnostics Common Stock as restricted stock units. The units were granted at a stated price of $0.00 per share as part of his compensation as a director, not through an open-market trade.

Is the Quest Diagnostics (DGX) Form 4 for Timothy C. Wentworth a share purchase or a grant?

The filing reflects a grant, not a purchase. It shows an acquisition coded as a grant or award of 215 restricted stock units, with no cash price per share, indicating compensation rather than an open-market transaction by Timothy C. Wentworth as a director.

How many Quest Diagnostics (DGX) shares does Timothy C. Wentworth hold after this Form 4 transaction?

After the reported grant, Timothy C. Wentworth’s directly owned position in Quest Diagnostics Common Stock shown in this filing is 215 shares. This amount matches the size of the restricted stock unit award disclosed and represents his reported direct holdings following the transaction.

What does the footnote in Timothy C. Wentworth’s Quest Diagnostics (DGX) Form 4 explain?

The footnote clarifies that the reported transaction represents an award of restricted stock units. This means the 215-share figure reflects stock-based compensation to Timothy C. Wentworth as a director of Quest Diagnostics, rather than a cash purchase or sale in the open market.

Does Timothy C. Wentworth’s Quest Diagnostics (DGX) Form 4 indicate any stock sales or disposals?

No disposals are reported in this Form 4. The transaction summary shows one acquisition event and zero sales or other dispositions, meaning the filing only records the grant of 215 restricted stock units to Timothy C. Wentworth with no shares sold or transferred away.